person

Benjamin B.

Country
France
Department
Endocrinology Diabetology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
54
Sites with multiple studies

Has run more than one trial at 54 of 468 partner sites.

Specializations

Diabetes Management

This investigator specializes in the study of double diabetes, a complex condition where features of both type 1 and type 2 diabetes are present. Their research explores innovative therapeutic approaches using GLP-1 receptor agonists for enhanced glycemic control.

  • Metabolic Control Optimization
  • Combination Therapy Approaches
  • Glycemic Target Management

The investigator's work focuses on evaluating treatment strategies for patients with complex diabetes presentations.

Therapeutic Innovation

The investigator conducts research in novel diabetes treatment modalities, particularly examining the potential of weekly administered medications for improving patient outcomes. Their expertise includes the evaluation of semaglutide therapy in specialized patient populations.

  • Advanced Treatment Protocols
  • Long-acting Therapeutics
  • Patient Response Assessment

Their work encompasses the development of targeted therapeutic strategies for complex metabolic conditions.

Clinical Monitoring

The investigator specializes in glycemic monitoring techniques and the assessment of time-in-range metrics for diabetes management. Their research involves evaluating treatment effectiveness through precise glycemic control measurements.

  • Glycemic Target Assessment
  • Treatment Response Monitoring
  • Long-term Outcome Evaluation

Their expertise extends to implementing advanced monitoring protocols for complex diabetes cases.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.